Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network

被引:26
|
作者
Zhao, Claire Y.
Greenstein, Joseph L.
Winslow, Raimond L. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA
基金
加拿大自然科学与工程研究理事会;
关键词
Cyclic nucleotide cross-talk signaling network; Phosphodiesterases; beta-adrenergic pathway; NO/cGMP/PKG pathway; Cardiac myocytes; Computational model; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; RAT VENTRICULAR MYOCYTES; CA2+ CHANNEL REGULATION; HEART-FAILURE; CGMP PHOSPHODIESTERASES; CAMP SIGNALS; GMP; CONTRACTION; PHOSPHORYLATION;
D O I
10.1016/j.yjmcc.2016.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The balanced signaling between the two cyclic nucleotides (cNs) cAMP and cGMP plays a critical role in regulating cardiac contractility. Their degradation is controlled by distinctly regulated phosphodiesterase isoenzymes (PDEs), which in turn are also regulated by these cNs. As a result, PDEs facilitate communication between the beta-adrenergic and Nitric Oxide (NO)/cGMP/Protein Kinase G (PKG) signaling pathways, which regulate the synthesis of cAMP and cGMP respectively. The phenomena in which the CAMP and cGMP pathways influence the dynamics of each other are collectively referred to as cN cross-talk. However, the cross-talk response and the individual roles of each PDE isoenzyme in shaping this response remain to be fully characterized. We have developed a computational model of the cN cross-talk network that mechanistically integrates the beta-adrenergic and NO/cGMP/PKG pathways via regulation of PDEs by both cNs. The individual model components and the integrated network model replicate experimentally observed activation-response relationships and temporal dynamics. The model predicts that, due to compensatory interactions between PDEs, NO stimulation in the presence of sub maximal beta-adrenergic stimulation results in an increase in cytosolic CAMP accumulation and corresponding increases in PICA-I and PICA-II activation; however, the potentiation is small in magnitude compared to that of NO activation of the NO/cGMP/PKG pathway. In a reciprocal manner, beta-adrenergic stimulation in the presence of sub-maximal NO stimulation results in modest cGMP elevation and corresponding increase in PKG activation. In addition, we demonstrate that PDE2 hydrolyzes increasing amounts of CAMP with increasing levels of beta-adrenergic stimulation, and hydrolyzes increasing amounts of cGMP with decreasing levels of NO stimulation. Finally, we show that PDE2 compensates for inhibition of PDE5 both in terms of cGMP and cAMP dynamics, leading to cGMP elevation and increased PKG activation, while maintaining whole-cell beta-adrenergic responses similar to that prior to PDE5 inhibition. By defining and quantifying reactions comprising cN cross-talk, the model characterizes the cross-talk response and reveals the underlying mechanisms of PDEs in this non-linear, tightly-coupled reaction system. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:215 / 227
页数:13
相关论文
共 50 条
  • [31] Cross-talk between TGFβ and EGFR signaling pathway:: Roles of hydrogen peroxide
    Lee, E
    Kim, JP
    Yi, JY
    Jeon, SH
    Son, YS
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 149A - 149A
  • [32] Cyclic AMP compartments and signaling specificity: Role of cyclic nucleotide phosphodiesterases
    Conti, Marco
    Mika, Delphine
    Richter, Wito
    JOURNAL OF GENERAL PHYSIOLOGY, 2014, 143 (01): : 29 - 38
  • [33] Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
    Bender, Andrew T.
    Beavo, Joseph A.
    PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 488 - 520
  • [34] Isoenzymes of cyclic nucleotide phosphodiesterases: Their physiological roles and pharmacological modulation
    Torphy, TJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R191 - R191
  • [35] Cross-talk in cell death signaling
    Roy, S
    Nicholson, DW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08): : F21 - F25
  • [36] Regulation of cardiac collagen - Angiotensin and cross-talk with local growth factors
    Dostal, DE
    HYPERTENSION, 2001, 37 (03) : 841 - 844
  • [37] Domain cross-talk in epigenetic regulation
    Fujimori, Danica
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [38] Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
    Ahmad, F.
    Murata, T.
    Shimizu, K.
    Degerman, E.
    Maurice, D.
    Manganiello, V.
    ORAL DISEASES, 2015, 21 (01) : E25 - E50
  • [39] Cross-talk signaling, transcriptional regulation, and functional development of Leydig cell progenitors
    Hwang, K
    Mitchell, L
    Kanzaki, M
    Morris, PL
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 490A - 490A
  • [40] Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure
    Barthou, Aurelien
    Kamel, Rima
    Leroy, Jerome
    Vandecasteele, Gregoire
    Fischmeister, Rodolphe
    M S-MEDECINE SCIENCES, 2024, 40 (6-7): : 534 - 543